Skip to main content
logo
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
29.83
-0.26 (-0.86%)
May 18, 2026, 4:00 PM EDT - Market closed

HRMY Revenue

Harmony Biosciences Holdings had revenue of $215.39M in the quarter ending March 31, 2026, with 16.59% growth. This brings the company's revenue in the last twelve months to $899.11M, up 20.71% year-over-year. In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth.

Revenue (ttm)
$899.11M
Revenue Growth
+20.71%
P/S Ratio
1.92
Revenue / Employee
$3,068,625
Employees
293
Market Cap
1.73B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025868.45M153.72M21.51%
Dec 31, 2024714.73M132.71M22.80%
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2,564.59%
Dec 31, 20196.00M--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Lakefront Biotherapeutics NV1.20B
Vericel292.09M
Syndax Pharmaceuticals217.17M
Zymeworks81.26M
Viridian Therapeutics70.92M
Agios Pharmaceuticals66.05M
uniQure18.09M
Taysha Gene Therapies7.47M
Revenue Rankings

HRMY News

More News